Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Rheumatology International
|
January 1, 1990
Stress (heat shock) proteins and rheumatic disease. New advance or just another band wagon?
N P Hurst
Annals of the Rheumatic Diseases
|
April 1, 1987
Molecular basis of activation and regulation of the phagocyte respiratory burst
N P Hurst
British Medical Journal (Clinical Research Ed.)
|
June 27, 1981
Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis
N P Hurst, G Nuki
British Journal of Rheumatology
|
August 1, 1995
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis
C M Lambert, N P Hurst
British Journal of Rheumatology
|
July 3, 1998
The short-term health outcome of out-patient rheumatology consultations in relation to rationing: a pilot study
N P Hurst, E R McRorie
Annals of the Rheumatic Diseases
|
February 1, 1984
Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids
N P Hurst, B Bessac, G Nuki
Annals of the Rheumatic Diseases
|
October 1, 1983
Functional defects of monocyte C3b receptor-mediated phagocytosis in rheumatoid arthritis (RA): evidence for an association with the appearance of a circulating population of non-specific esterase-negative mononuclear phagocytes
N P Hurst, G Nuki, T Wallington
Clinical and Experimental Immunology
|
February 1, 1984
Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE)
N P Hurst, G Nuki, T Wallington
British Journal of Rheumatology
|
April 1, 1987
IgG (kappa) paraproteinaemia and arthritis
N P Hurst, W Smith, D R Henderson
Biochemical Pharmacology
|
July 1, 1989
Inhibition of protein kinase C activity by the antirheumatic drug auranofin
M Froscio, A W Murray, N P Hurst
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Rheumatology International
|
January 1, 1990
Stress (heat shock) proteins and rheumatic disease. New advance or just another band wagon?
N P Hurst
Annals of the Rheumatic Diseases
|
April 1, 1987
Molecular basis of activation and regulation of the phagocyte respiratory burst
N P Hurst
British Medical Journal (Clinical Research Ed.)
|
June 27, 1981
Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis
N P Hurst, G Nuki
British Journal of Rheumatology
|
August 1, 1995
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis
C M Lambert, N P Hurst
British Journal of Rheumatology
|
July 3, 1998
The short-term health outcome of out-patient rheumatology consultations in relation to rationing: a pilot study
N P Hurst, E R McRorie
Annals of the Rheumatic Diseases
|
February 1, 1984
Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids
N P Hurst, B Bessac, G Nuki
Annals of the Rheumatic Diseases
|
October 1, 1983
Functional defects of monocyte C3b receptor-mediated phagocytosis in rheumatoid arthritis (RA): evidence for an association with the appearance of a circulating population of non-specific esterase-negative mononuclear phagocytes
N P Hurst, G Nuki, T Wallington
Clinical and Experimental Immunology
|
February 1, 1984
Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE)
N P Hurst, G Nuki, T Wallington
British Journal of Rheumatology
|
April 1, 1987
IgG (kappa) paraproteinaemia and arthritis
N P Hurst, W Smith, D R Henderson
Biochemical Pharmacology
|
July 1, 1989
Inhibition of protein kinase C activity by the antirheumatic drug auranofin
M Froscio, A W Murray, N P Hurst
Page
of 5